ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 89 filers reported holding ANTARES PHARMA INC in Q1 2014. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $100,000 | -38.3% | 50,000 | 0.0% | 0.00% | – |
Q3 2017 | $162,000 | +153.1% | 50,000 | +150.0% | 0.00% | – |
Q2 2017 | $64,000 | +12.3% | 20,000 | 0.0% | 0.00% | – |
Q1 2017 | $57,000 | +21.3% | 20,000 | 0.0% | 0.00% | – |
Q4 2016 | $47,000 | +38.2% | 20,000 | 0.0% | 0.00% | – |
Q3 2016 | $34,000 | +61.9% | 20,000 | 0.0% | 0.00% | – |
Q2 2016 | $21,000 | +23.5% | 20,000 | 0.0% | 0.00% | – |
Q1 2016 | $17,000 | -29.2% | 20,000 | 0.0% | 0.00% | – |
Q4 2015 | $24,000 | -29.4% | 20,000 | 0.0% | 0.00% | – |
Q3 2015 | $34,000 | -19.0% | 20,000 | 0.0% | 0.00% | – |
Q2 2015 | $42,000 | -22.2% | 20,000 | 0.0% | 0.00% | – |
Q1 2015 | $54,000 | +5.9% | 20,000 | 0.0% | 0.00% | – |
Q4 2014 | $51,000 | +37.8% | 20,000 | 0.0% | 0.00% | – |
Q3 2014 | $37,000 | -30.2% | 20,000 | 0.0% | 0.00% | – |
Q2 2014 | $53,000 | -24.3% | 20,000 | 0.0% | 0.00% | – |
Q1 2014 | $70,000 | -22.2% | 20,000 | 0.0% | 0.00% | – |
Q4 2013 | $90,000 | +11.1% | 20,000 | 0.0% | 0.00% | – |
Q3 2013 | $81,000 | -2.4% | 20,000 | 0.0% | 0.00% | – |
Q2 2013 | $83,000 | – | 20,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|